Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Drugs Controller General of India

Spanish pharma MNC’s facility in Genome Valley opened

Insud Pharma inaugurated its Oligonucleotides centre in Genome Valley, India, approved by U.S. FDA, Spanish Health Agency, and Drugs Controller General of India. It will produce a novel antisense Oligonucleotide for the treatment of Spinal Muscular Atrophy (SMA) and export products to various markets. Chemo India Formulation, a wholly-owned subsidiary,…

The Hindu · Sep 14, 2023

India tests samples of cough syrup linked to deaths of children in Gambia

India said it is testing samples of cough syrups produced by local manufacturer Maiden Pharmaceuticals for export after the World Health Organization said its products were linked to the deaths of dozens of children in Gambia.

Reuters · Oct 6, 2022

COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine. Read more on Dynamite News:

Dynamite News · Sep 6, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Serum Institute of India to launch vaccine to prevent cervical cancer

Drugs Controller General of India’s approval of SII’s anti-cervical cancer vaccine follows the recommendation of the institute’s COVID-19 vaccine in June last year

The Hindu · Jul 13, 2022

DCGI grants emergency use authorisation to Corbevax for those aged 5-12, Covaxin for 6-12 age group, ZycovD for above 12 year olds: Report

The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to BharatBiotech's COVAXIN for children between the age of 6-12 years, news agency ANI tweeted on Tuesday citing sources.

The Times of India · Apr 26, 2022

Novavax says its COVID vaccine gets India authorisation for teens

Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.

Reuters · Mar 22, 2022

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.

The Hindu · Mar 5, 2022

Read news from The Economist, FT, and more,
with one subscription

DGCI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.

Dynamite News · Jan 27, 2022

Coverage From

People

Adar Poonawalla

16 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Serum Institute of India

23 stories

Covishield

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.